164 related articles for article (PubMed ID: 28383252)
1. Prescreening of Nicotine Hapten Linkers in Vitro To Select Hapten-Conjugate Vaccine Candidates for Pharmacokinetic Evaluation in Vivo.
Arutla V; Leal J; Liu X; Sokalingam S; Raleigh M; Adaralegbe A; Liu L; Pentel PR; Hecht SM; Chang Y
ACS Comb Sci; 2017 May; 19(5):286-298. PubMed ID: 28383252
[TBL] [Abstract][Full Text] [Related]
2. Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice.
Pryde DC; Jones LH; Gervais DP; Stead DR; Blakemore DC; Selby MD; Brown AD; Coe JW; Badland M; Beal DM; Glen R; Wharton Y; Miller GJ; White P; Zhang N; Benoit M; Robertson K; Merson JR; Davis HL; McCluskie MJ
PLoS One; 2013; 8(10):e76557. PubMed ID: 24098532
[TBL] [Abstract][Full Text] [Related]
3. Molecular attributes of conjugate antigen influence function of antibodies induced by anti-nicotine vaccine in mice and non-human primates.
McCluskie MJ; Thorn J; Mehelic PR; Kolhe P; Bhattacharya K; Finneman JI; Stead DR; Piatchek MB; Zhang N; Chikh G; Cartier J; Evans DM; Merson JR; Davis HL
Int Immunopharmacol; 2015 Apr; 25(2):518-27. PubMed ID: 25737198
[TBL] [Abstract][Full Text] [Related]
4. Optimization of a multivalent peptide vaccine for nicotine addiction.
Zeigler DF; Roque R; Clegg CH
Vaccine; 2019 Mar; 37(12):1584-1590. PubMed ID: 30772068
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR
Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207
[TBL] [Abstract][Full Text] [Related]
6. A conjugate vaccine using enantiopure hapten imparts superior nicotine-binding capacity.
Lockner JW; Lively JM; Collins KC; Vendruscolo JC; Azar MR; Janda KD
J Med Chem; 2015 Jan; 58(2):1005-11. PubMed ID: 25493909
[TBL] [Abstract][Full Text] [Related]
7. A new strategy for improved nicotine vaccines using conformationally constrained haptens.
Meijler MM; Matsushita M; Altobell LJ; Wirsching P; Janda KD
J Am Chem Soc; 2003 Jun; 125(24):7164-5. PubMed ID: 12797775
[TBL] [Abstract][Full Text] [Related]
8. Hapten optimization for cocaine vaccine with improved cocaine recognition.
Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM
Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171
[TBL] [Abstract][Full Text] [Related]
9. Nicotine hapten structure, antibody selectivity and effect relationships: results from a nicotine vaccine screening procedure.
de Villiers SHL; Lindblom N; Kalayanov G; Gordon S; Baraznenok I; Malmerfelt A; Marcus MM; Johansson AM; Svensson TH
Vaccine; 2010 Mar; 28(10):2161-2168. PubMed ID: 20060511
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a promiscuous T cell epitope peptide based conjugate vaccine against benzo[a]pyrene: redirecting antibodies to the hapten.
Schellenberger MT; Grova N; Farinelle S; Willième S; Revets D; Muller CP
PLoS One; 2012; 7(5):e38329. PubMed ID: 22666501
[TBL] [Abstract][Full Text] [Related]
11. ELISA screening of monoclonal antibodies to haptens: influence of the chemical structure of hapten-protein conjugates.
Danilova NP
J Immunol Methods; 1994 Jul; 173(1):111-7. PubMed ID: 8034978
[TBL] [Abstract][Full Text] [Related]
12. The effect of preexisting anti-carrier immunity on subsequent responses to CRM197 or Qb-VLP conjugate vaccines.
McCluskie MJ; Evans DM; Zhang N; Benoit M; McElhiney SP; Unnithan M; DeMarco SC; Clay B; Huber C; Deora A; Thorn JM; Stead DR; Merson JR; Davis HL
Immunopharmacol Immunotoxicol; 2016 Jun; 38(3):184-96. PubMed ID: 27121368
[TBL] [Abstract][Full Text] [Related]
13. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.
Zhao Z; Powers K; Hu Y; Raleigh M; Pentel P; Zhang C
Biomaterials; 2017 Apr; 123():107-117. PubMed ID: 28167389
[TBL] [Abstract][Full Text] [Related]
14. Anti-nicotine vaccines: Comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates.
McCluskie MJ; Thorn J; Gervais DP; Stead DR; Zhang N; Benoit M; Cartier J; Kim IJ; Bhattacharya K; Finneman JI; Merson JR; Davis HL
Int Immunopharmacol; 2015 Dec; 29(2):663-671. PubMed ID: 26404190
[TBL] [Abstract][Full Text] [Related]
15. The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.
Laudenbach M; Tucker AM; Runyon SP; Carroll FI; Pravetoni M
Vaccine; 2015 Nov; 33(46):6332-9. PubMed ID: 26409811
[TBL] [Abstract][Full Text] [Related]
16. Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.
Taylor JJ; Laudenbach M; Tucker AM; Jenkins MK; Pravetoni M
J Immunol Methods; 2014 Mar; 405():74-86. PubMed ID: 24462800
[TBL] [Abstract][Full Text] [Related]
17. Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.
Matyas GR; Mayorov AV; Rice KC; Jacobson AE; Cheng K; Iyer MR; Li F; Beck Z; Janda KD; Alving CR
Vaccine; 2013 Jun; 31(26):2804-10. PubMed ID: 23624097
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.
Carroll FI; Blough BE; Pidaparthi RR; Abraham P; Gong PK; Deng L; Huang X; Gunnell M; Lay JO; Peterson EC; Owens SM
J Med Chem; 2011 Jul; 54(14):5221-8. PubMed ID: 21682289
[TBL] [Abstract][Full Text] [Related]
19. Effect of different hapten-carrier conjugation ratios and molecular orientations on antibody affinity against a peptide antigen.
Pedersen MK; Sorensen NS; Heegaard PM; Beyer NH; Bruun L
J Immunol Methods; 2006 Apr; 311(1-2):198-206. PubMed ID: 16574142
[TBL] [Abstract][Full Text] [Related]
20. Isolation of Anti-Hapten Antibodies by Fluorescence-Activated Cell Sorting of Yeast-Displayed B-Cell Receptor Gene Repertoires.
Jäger S; Krah S; Könning D; Rosskopf J; Dickgiesser S; Rasche N; Kolmar H; Hecht S; Schröter C
Methods Mol Biol; 2020; 2070():267-287. PubMed ID: 31625101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
